SCHEMBL31283

SCHEMBL31283

CC(=NO)c1cc(N(COCC[SiH2]Cc2cc(C)cc(C)c2)COCC[SiH2]Cc2cc(C)cc(C)c2)n2nccc2n1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31080 0.81 CRHR1 (0.32) CRHR1
SCHEMBL31079 0.81 CRHR1 (0.32) CRHR1
SCHEMBL17787544 0.81 CRHR1 (0.32) CRHR1
SCHEMBL30498 0.77 PDE10A (0.32) CRHR1
SCHEMBL31284 0.76
SCHEMBL31282 0.76
SCHEMBL596486 0.75 ALDH1A1 (0.37) CRHR1
SCHEMBL7881389 0.70 CRHR1 (0.30) CRHR1
SCHEMBL30183 0.69 CRHR1 (0.33) CRHR1
SCHEMBL10280617 0.69 CRHR1 (0.33) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2608668-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN Merck Sharp & Dohme Corp. (US) 2013-07-03 EP disclosed
WO-2012027234-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN SCHERING CORPORATION (US) 2012-03-01 WO disclosed